PMGC Holdings Announces Payment Agreement Securing Elevai Skincare Royalties

What Happened

• On September 18, 2026, PMGC Holdings Inc. (ticker: ELAB) announced via press release (furnished on Form 8‑K) that it and its wholly owned subsidiary, NorthStrive Biosciences Inc., entered into a payment agreement with Longevity Health Holdings, Inc. The agreement is intended to secure the royalty payments owed in connection with PMGC’s January 2025 sale of its Elevai Skincare business.

Key Details

• Filing: Current Report on Form 8‑K, Item 7.01 (Regulation FD Disclosure), dated September 18, 2026.
• Parties: PMGC Holdings Inc. and subsidiary NorthStrive Biosciences Inc. with Longevity Health Holdings, Inc.
• Subject: Payment agreement to secure royalty payments related to PMGC’s January 2025 sale of the Elevai Skincare business.
• Exhibit: The company furnished a press release as Exhibit 99.1 to the Form 8‑K.

Why It Matters

• The agreement relates directly to cash flows tied to PMGC’s prior divestiture of the Elevai Skincare business and is intended to secure royalty payments owed to PMGC.
• For investors, this is a disclosure about steps the company is taking to formalize collection of post‑sale royalties; the press release and any future filings should be consulted for specifics on timing, amounts, and financial impact.